Tokyo, Dec. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060142) titled 'A retrospective study of the efficacy and adverse events of cholangioscopy and pancreatoscopy' on Dec. 22.
Study Type:
Observational
Primary Sponsor:
Institute - Shimane University
Condition:
Condition - pancreatobiliary disease
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the efficacy and adverse events of cholangioscopy and pancreaticoscopy.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Cases in which cholangioscopy or pancreatoscopy was attempted between April 2012 and October 2025 (including cases in which insertion into the bile duct or pancreatic duct was unsuccessful).
Key exclusion criteria - Cases with insufficient endoscopic reports
Target Size - 50
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 12 Month 20 Day
Anticipated trial start date - 2025 Year 12 Month 22 Day
Last follow-up date - 2026 Year 10 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068788
Disclaimer: Curated by HT Syndication.
